|
|
PDF
Version ![PDF](/web/20071212035004im_/http://www.phac-aspc.gc.ca/gfx_common/pdf.gif)
Canadian Summary:
During week 08, influenza activity overall in Canada is increasing with
widespread activity being reported in Saskatchewan and parts of southern
British Columbia. Localized activity was reported in British Columbia,
Alberta, Ontario, Quebec and Nova Scotia whereas the rest of the country
reported sporadic or no activity (see map). So far
this season, influenza activity in Canada is lower compared to the last
two seasons.
Over the one week period, the Public Health Agency of Canada received
3193 reports of laboratory tests for influenza of which 383 (12%) were
positive for influenza virus. Fifty-nine percent of the positive influenza
detections were from the west (Saskatchewan, Alberta & British Columbia)
and 26% were from Ontario. In the current season to date, a mix of influenza
A (56%) and influenza B (44%) viruses have been detected in Canada (see
table) whereas influenza A virus detections predominated
in the previous two seasons. The ILI consultation rate was calculated
as 22 per 1000 patient visits in week 08, which is below the expected
range for this week (see ILI graph).. During week 08,
38 new outbreaks were reported: 15 were in LTCF's; 20 were in schools;
1 was in a hospital; and 2 were in other settings. To date this season,
57 LTCF outbreaks have been reported.
Antigenic Characterization:
Since the start of the 2005-2006 influenza season, the National Microbiology
Laboratory (NML) has antigenically characterized 394 influenza viruses:
202 A/California/07/2004(H3N2)-like viruses; 7 A/New Caledonia/20/1999(H1N1)-like
viruses; 136 B/Hong Kong/330/2001-like and 44 B/Malaysia/2506/2004-like
viruses both belonging to the B/Victoria/2/1987 lineage; and 5 B/Shanghai/361/2002-like
viruses belonging to the B/Yamagata/16/1988 lineage. The B/Malaysia/2506/2004-like
strain is the WHO-recommended influenza B component for the Northern
Hemisphere 2006-2007 influenza vaccine.
* The 2005-2006 season Canadian vaccine contains an A/New Caledonia/20/1999(H1N1)-like,
an A/California/7/2004(H3N2)-like, and a B/Shanghai/361/2002-like virus
strain.
Vaccine Match:
To date, 100% of the influenza A strains characterized by the NML have
matched those included in the 2005-2006 Canadian vaccine. However, only
3% of the influenza B characterizations have matched the current vaccine
strain. The remaining 97% of the influenza B strains characterized have
been B/Hong Kong/330/2001-like and B/Malaysia/2506/2004-like viruses,
which belong to a separate lineage of viruses not covered by this year's
vaccine.
Influenza-associated Pediatric Hospitalizations:
During week 08, 15 new laboratory-confirmed influenza-associated hospitalizations
were reported through the IMPACT (Immunization Monitoring Program ACTive)
network. Since the start of this influenza season, 84 cases have been
reported to IMPACT from 10 of the 12 pediatric hospitals. Since the
start of the season, 1 influenza-associated pediatric death has been
reported to IMPACT.
International:
CDC: During week 07, overall influenza activity increased in
the United States with the majority of widespread and regional activity
being reported in the eastern and central states. The proportion of
patient visits to sentinel providers for ILI (2.8%) was above baseline
levels and the proportion of deaths due to pneumonia and influenza (7.3%)
was below baseline levels. Since 1 October 2005, the CDC has antigenically
characterized 253 influenza viruses: 208 A(H3N2) viruses (168 were A/California/07/2004-like
viruses and 40 showed reduced titers with antisera produced against A/California/07/2004-like
viruses); 14 A(H1) viruses (12 were similar antigenically to the hemagglutinin
protein of the A/New Caledonia/20/1999-like viruses and 2 showed reduced
titers with antisera against A/New Caledonia/20/1999-like viruses); and
31 influenza B viruses (19 were B/Yamagata/16/1988-lineage viruses and
12 were B/Victoria/2/1987-lineage viruses). Of the 40 low-reacting A(H3N2)
viruses, 14 were tested with antisera produced against A/Wisconsin/67/2005
and 10 were A/Wisconsin/67/2005-like and is the A/H3N2 component selected
for the 2006/2007 Northern Hemisphere influenza vaccine.
EISS: Clinical influenza activity in Europe has been
moderate so far this season. In week 08, Lithuania reported a high intensity
of clinical influenza activity associated with influenza B virus. Whilst
clinical influenza activity is now declining in a number of countries
(e.g. France), some countries have seen very little influenza activity
so far this season (e.g. Hungary, Poland and Slovenia). Since the start
of the season, more influenza B viruses (68%) have been reported than
influenza A viruses (32%) for Europe as a whole.
Human Avian Influenza:
Since 26 February 2006, the WHO reported 3 new human cases with the H5N1
avian influenza virus: 1 case was from Indonesia and resulted in death;
and 2 cases were from China, both of whom are in critical condition.
Antiviral Resistance
The Public
Health Agency of Canada recommends recommends that health
care providers in Canada not prescribe amantadine to treat and prevent
influenza during the current flu season following testing showing viruses
currently in circulation in Canada and the US are resistant to the drug.
|
Total number of influenza tests
performed and number of positive tests by province/territory of testing
laboratory, Canada, 2005-2006
Province
of
reporting
laboratories |
Report
Period:
February 19, 2006 to February 25, 2006 |
Season
to Date:
August 28, 2005 - February 25,
2006 |
Total
#
Influenza
Tests |
#
of Positive Tests |
Total
#
Influenza
Tests |
#
of Positive Tests |
Influenza
A |
Influenza
B |
Total |
Influenza
A |
Influenza
B |
Total |
NL |
83 |
1 |
13 |
14 |
427 |
3 |
14 |
17 |
PE |
8 |
0 |
0 |
0 |
88 |
2 |
0 |
2 |
NS |
49 |
0 |
2 |
2 |
550 |
1 |
5 |
6 |
NB |
44 |
1 |
1 |
2 |
634 |
1 |
2 |
3 |
QC |
542 |
24 |
0 |
24 |
8777 |
89 |
6 |
95 |
ON |
955 |
51 |
50 |
101 |
13319 |
195 |
88 |
283 |
MB |
78 |
14 |
1 |
15 |
1383 |
26 |
12 |
38 |
SK |
320 |
40 |
45 |
85 |
3353 |
135 |
138 |
273 |
AB |
887 |
53 |
34 |
87 |
10756 |
274 |
472 |
746 |
BC |
227 |
29 |
24 |
53 |
3495 |
347 |
177 |
524 |
Canada |
3193 |
213 |
170 |
383 |
42782 |
1073 |
914 |
1987 |
|
Specimens from NT, YT, and NU are sent to reference laboratories
in other provinces.
Note: Cumulative data includes updates to previous
weeks; due to reporting delays, the sum of weekly report totals do not
add up to cumulative totals.
Abbreviations: Newfoundland/Labrador (NL), Prince Edward
Island (PE), New Brunswick (NB), Nova Scotia (NS), Quebec (QC), Ontario
(ON), Manitoba (MB), Saskatchewan (SK), Alberta (AB), British Columbia
(BC), Yukon (YT), Northwest Territories (NT), Nunavut (NU)
Respiratory virus laboratory detections in Canada, by geographic
regions, are available weekly on the following website:
<http://www.phac-aspc.gc.ca/bid-bmi/dsd-dsm/rvdi-divr/index.html>
![top](/web/20071212035004im_/http://www.phac-aspc.gc.ca/fluwatch/gfx/topline600.gif)
Number of influenza surveillance
regions reporting widespread or localized influenza activity,
Canada, by report week, 2005-2006 (N=76)
![](/web/20071212035004im_/http://www.phac-aspc.gc.ca/fluwatch/05-06/w08_06/figures/flu0506-leg1-e.gif)
sub-regions within the province or territory as defined by the
provincial/territorial epidemiologist. Graph may change as late returns
come in.
Influenza tests reported and
percentage of tests positive, Canada, by report week, 2005-2006
![Influenza tests reported and percentage of tests positive, Canada, by report week, 2005-2006](/web/20071212035004im_/http://www.phac-aspc.gc.ca/fluwatch/05-06/w08_06/figures/0806fg2e.gif)
![](/web/20071212035004im_/http://www.phac-aspc.gc.ca/fluwatch/05-06/w08_06/figures/flu0506-leg2-e.gif)
Percent positive influenza tests,
compared to other respiratory viruses by reporting week, Canada, 2005-2006
![Percent positive influenza tests, compared to other respiratory viruses by reporting week, Canada, 2005-2006](/web/20071212035004im_/http://www.phac-aspc.gc.ca/fluwatch/05-06/w08_06/figures/0806fg3e.gif)
![](/web/20071212035004im_/http://www.phac-aspc.gc.ca/fluwatch/05-06/w08_06/figures/flu0506-leg3-e.gif)
Influenza strain characterization,
Canada, cumulative, 2005-2006 influenza season by the Respiratory Viruses
Section at the National Microbiology Laboratory
[N=394]
![Influenza strain characterization, Canada, cumulative, 2005-2006 influenza season by the Respiratory Viruses Section at the National Microbiology Laboratory](/web/20071212035004im_/http://www.phac-aspc.gc.ca/fluwatch/05-06/w08_06/figures/0806fg4e.gif)
(Strain characterization, number identified, per cent
of total number)
NACI recommends that the trivalent vaccine for the 2005-2006
season in Canada contain A/New Caledonia/20/99 (H1N1)-like, A/California/7/2004
(H3N2)-like, and B/Shanghai/361/2002-like virus antigens.
* The B/Shanghai/361/2002-like virus belongs to the B/Yamagata/16/88
lineage; the B/Hong Kong/330/01-like and B/Malaysia/2506/2004-like viruses
belong to the B/Victoria/02/87 lineage and are not covered by this year's
vaccine.
Influenza-like illness (ILI)
reporting rates, Canada, by report week, 2005-2006 compared to 1996/97
through 2004/2005 seasons
![Influenza-like illness (ILI) reporting rates, Canada, by report week, 2005-2006 compared to 1996/97 through 2004/2005 seasons](/web/20071212035004im_/http://www.phac-aspc.gc.ca/fluwatch/05-06/w08_06/figures/0806fg5e.gif)
![](/web/20071212035004im_/http://www.phac-aspc.gc.ca/fluwatch/05-06/w08_06/figures/flu0506-leg5-e.gif)
Note: No data available for mean rate in previous years
for weeks 21 to 39 (1996-1997 through 2002-2003 seasons).
Number of New Outbreaks in Long
Term Care Facilities by Report Week, Canada, 2005-2006
![Number of New Outbreaks in Long Term Care Facilities by Report Week, Canada, 2005-2006](/web/20071212035004im_/http://www.phac-aspc.gc.ca/fluwatch/05-06/w08_06/figures/0806fg6e.gif)
![](/web/20071212035004im_/http://www.phac-aspc.gc.ca/fluwatch/05-06/w08_06/figures/flu0506-leg6-e.gif)
|